此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Uncovering Neurocognitive Mechanisms and Enhancement of Exposure-based Fear Learning With Cognitive Training

2026年9月3日 更新者:Jessica Bomyea、University of California, San Diego
Anxiety disorders remain are among the most prevalent psychiatric conditions and are associated with negative outcomes spanning poor health to increased suicide risk. While exposure therapy is recognized as a gold standard empirically supported treatment, many individuals fail to achieve adequate response. Exposure therapy is grounded in fear extinction learning models, which suggest that anxiety diminishes when individuals repeatedly confront their fears. To improve exposure-based interventions, it is critical to enhance our understanding of underlying mechanisms of fear extinction and how to better target these mechanisms. Fear extinction requires basic neurocognitive abilities that allow individuals to learn from and adapt to experiences confronting feared situations. Emerging cross sectional and experimental data suggest that working memory is a particularly important neurocognitive process that is associated with fear learning outcomes. By enhancing working memory through experimental manipulations like cognitive training, we may improve the fear extinction learning processes essential for successful exposure therapy. Unlike other neurocognitive enhancements (e.g., medications), computer-based working memory training offers high mechanistic precision, ease of administration, and low cost. The long-term goal of this research is to develop a novel mechanistic understanding of the neurocognitive processes involved in exposure-based fear extinction learning, ultimately aiming to improve interventions for anxiety disorders. This study will test the effects of manipulating working memory prior to a massed exposure paradigm, comparing working memory training plus massed exposure (WMT+Ex) to a sham training plus massed exposure (ST+Ex) condition. Using public speaking anxiety as a clinical exemplar, we will employ a rigorous experimental trial design combined with a validated single-visit speech exposure paradigm to assess fear extinction learning outcomes through multiple measures, including behavioral, physiological, neural, and self-report. The central hypothesis is that WMT+Ex will improve markers of fear extinction learning considered to underlie clinical response in exposure therapy. Specific aims are to 1) determine the extent to which working memory training delivered prior to massed exposure improves behavioral and neural markers of fear extinction learning, and 2) evaluate the effects of working memory training delivered prior to massed exposure on fear extinction learning occurring during exposure. This study is expected to achieve two goals: first, to advance our understanding of the neurocognitive mechanisms of fear extinction through a rigorous experimental design, and second, to validate a combined working memory training and exposure paradigm. If successful in enhancing fear extinction, this approach could be further explored in therapeutic formats to assess its clinical effects.

研究概览

研究类型

介入性

注册 (估计的)

120

阶段

  • 不适用

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  1. age 18-65
  2. fluent in English
  3. diagnosis of social anxiety disorder (generalized or performance-only) with Personal Report of Public Speaking Anxiety (PRPSA) score of ≥120 at screening
  4. 6-week stability if receiving other (non-anxiety focused) psychosocial treatment

Exclusion Criteria:

  1. past 3-mo diagnosis of moderate or greater alcohol or substance use disorder
  2. lifetime history of psychotic or bipolar I disorders
  3. acute suicidality necessitating immediate clinical intervention
  4. neurodegenerative or neurodevelopmental disorders
  5. history of neurological condition
  6. conditions that are unsafe for MRI (e.g., metal in body)
  7. currently receiving psychosocial treatment for anxiety or related condition
  8. currently receiving psychiatric pharmacotherapy

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:四人间

武器和干预

参与者组/臂
干预/治疗
有源比较器:Cognitive training
Training to enhance cognitive functioning
Repeated practice with cognitive skills to enhance performance
Sham cognitive training
假比较器:Sham training
Computer interface designed to control for general task parameters
Repeated practice with cognitive skills to enhance performance
Sham cognitive training

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Fear extinction
大体时间:Change from baseline day 1 to post-intervention day 2
threat expectancy ratings to the CS+ during late extinction learning
Change from baseline day 1 to post-intervention day 2
Subjective Units of Distress
大体时间:Change from baseline speech to post speech (all within day 1)
Ratings of distress during speeches
Change from baseline speech to post speech (all within day 1)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2027年1月1日

初级完成 (估计的)

2031年6月1日

研究完成 (估计的)

2031年9月1日

研究注册日期

首次提交

2026年8月31日

首先提交符合 QC 标准的

2026年9月3日

首次发布 (实际的)

2026年9月4日

研究记录更新

最后更新发布 (实际的)

2026年9月4日

上次提交的符合 QC 标准的更新

2026年9月3日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • 812820
  • 1R01MH141088-01A1 (美国 NIH 拨款/合同:NIMH)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

NIH NDA

IPD 共享时间框架

see NIH for details

IPD 共享访问标准

see NIH for details

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅